Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE: Safety Overview

Metric RUCAPARIB CAMSYLATE SACCHAROMYCES CEREVISIAE
Total FAERS Reports 8,240 284
Deaths Reported 448 85
Death Rate 5.4% 29.9%
Hospitalizations 1,148 159
Average Patient Age 65.1 yrs 62.1 yrs
% Female Patients 95.2% 59.4%
FDA Approval Date Dec 19, 2016 N/A
Manufacturer pharmaand GmbH DNA Labs, Inc.
Route ORAL SUBLINGUAL
Marketing Status Prescription N/A